Research, partnerships and case studies
Solu to Enable a Cedars-Sinai Medical Center Research Study on Epidemiological and Antibiotic Resistance of Hospital Infections with Genomics
Cedars-Sinai Medical Center and health technology company Solu announce today a partnership to study and understand hospital-acquired infections from an epidemiological and antibiotic resistance perspective. Solu offers an end-to-end service that provides insight into the causes of antibiotic resistance and whether the infection is hospital-acquired.
Analyzing Candida genomes with candida.app & Solu
The emerging fungal pathogen Candida auris is a growing public health threat due to its fast spread, multidrug-resistance, high transmissibility, and high mortality rates. We created a free web application called candida.app for fast and easy genomic characterization of C.auris isolates.
Investigating a Salmonella Typhi outbreak with Solu Platform
Salmonella Typhi is a bacterial pathogen that causes typhoid fever, a serious illness affecting millions of people worldwide. In this case study, we will explore the use of the Solu platform to investigate a Salmonella Typhi outbreak and analyze the genomic data associated with it.
Validating the results of candida.app and Solu Platform
Candida auris is an emerging health threat, and better genomic analysis tool are needed for its surveillance. Candida.app is a free, user-friendly tool for genomic analysis of C. auris isolates. This validation study shows that Solu and candida.app are accurate for genomıc characterization of Candida auris.